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Abstract The Q-subunit of citrate lyase (EC 4.1.3.6) contains
the prosthetic group 2P-(5Q-phosphoribosyl)-3P-dephospho-CoA
and serves as an acyl carrier protein (ACP). We recently showed
that in Escherichia coli the proteins CitG and CitX are essential
for holo-ACP synthesis and provided evidence that CitG
catalyzes the formation of a prosthetic group precursor from
ATP and dephospho-CoA, which is subsequently attached via
phosphodiester linkage to apo-ACP by CitX. Here we prove that
CitG indeed catalyzes the conversion of ATP and dephospho-
CoA to adenine and 2P-(5Q-triphosphoribosyl)-3P-dephospho-
CoA, the predicted precursor of the prosthetic group. Further-
more, this precursor was transferred by CitX to apo-ACP,
yielding holo-ACP. Thus, our proposed mechanism for holo-
ACP synthesis could be verified. ß 2000 Federation of Euro-
pean Biochemical Societies. Published by Elsevier Science B.V.
All rights reserved.
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1. Introduction
Citrate lyase catalyzed the Mg2-dependent cleavage of cit-
rate to acetate and oxaloacetate. This reaction represents the
initial step in all known bacterial citrate fermentation path-
ways [1^4]. Citrate lyase of the enterobacterial species Kleb-
siella pneumoniae consists of three di¡erent subunits K (55
kDa), L (32 kDa) and Q (11 kDa). The native enzyme is com-
posed of six copies of each of the three subunits, forming a
550 kDa complex [5,6]. Whereas the K- and the L-subunits
possess catalytic activity, the Q-subunit serves as an acyl car-
rier protein (ACP) [7]. It carries the prosthetic group 2P-(5Q-
phosphoribosyl)-3P-dephospho-CoA (Fig. 1) which is attached
via phosphodiester linkage to serine-14 in the enzymes from
K. pneumoniae [8^12] and Escherichia coli [13]. As a prereq-
uisite for catalytic activity, the thiol group of the enzyme-
bound CoA derivative has to be converted to the acetyl-thio-
ester derivative by the action of citrate lyase ligase (EC
6.2.1.22) [14,15]. The K-subunit then catalyzes the exchange
of the acetyl group with a citryl group, forming citryl-ACP
and acetate. The L-subunit subsequently mediates the Mg2-
dependent conversion of citryl-ACP into acetyl-ACP and ox-
aloacetate [16].
In K. pneumoniae, the genes encoding the Q- (CitD), L-
(CitE) and K-subunit (CitF) of citrate lyase are part of the
citCDEFG operon, with citC encoding citrate lyase ligase [17].
This operon is induced under anoxic conditions in the pres-
ence of citrate and Na ions. Its expression is strictly depen-
dent on the CitA/CitB two-component regulatory system [18^
20]. In E. coli, a similar gene cluster was identi¢ed, cit-
CDEFXG [21], which di¡ers by the presence of an additional
gene (citX) [22]. Like in K. pneumoniae, expression of the
E. coli citC operon appears to be regulated by the CitA/
CitB (DpiB/DpiA) two-component system [23].
We could recently demonstrate [13] that the formation of
holo-citrate lyase is dependent on CitG (33 kDa) and CitX (20
kDa). Expression of the K. pneumoniae citCDEFG genes in E.
coli resulted in the formation of an inactive citrate lyase, be-
cause only the apo-form of the ACP was formed [17]. Coex-
pression of the E. coli citX gene could complement this de¢-
ciency and led to the formation of an active holo-citrate lyase
[13]. Depending on the presence or absence of CitX and CitG,
three di¡erent-sized ACP forms could be detected in vivo.
Holo-ACP was only synthesized if CitX and CitG were
present, whereas in the absence of the two proteins or of
CitX alone, apo-ACP was formed. If CitG was absent, but
CitX present, an intermediate-sized ACP was found that was
identi¢ed as adenylylated ACP with the AMP residue at-
tached to serine-14. The deduced function of CitX as an
apo-ACP nucleotidyl transferase (EC 2.7.7) could be veri¢ed
in vitro, where the enzyme also accepts CTP, GTP and UTP
as substrates [13].
To test whether AMP-ACP is an intermediate in the con-
version of apo- into holo-ACP, an in vitro system was estab-
lished that allowed the formation of holo-ACP with puri¢ed
CitG and CitX as catalysts and apo-ACP, ATP and dephos-
pho-CoA as substrates [13]. In this process, ATP could not be
substituted by other nucleotides. Importantly, it was not pos-
sible to convert AMP-ACP into holo-ACP by incubation with
CitG and dephospho-CoA. This result pointed to an alterna-
tive pathway of holo-ACP formation, where ¢rst a precursor
of the prosthetic group is synthesized from ATP and dephos-
pho-CoA by CitG. This precursor is subsequently transferred
to apo-ACP by CitX. According to the structure of the pros-
thetic group and its precursors ATP and dephospho-CoA,
2P-(5Q-triphosphoribosyl)-3P-dephospho-CoA was deduced to
be the intermediate formed by CitG. The proposed pathway
for the conversion of apo- into holo-ACP is shown in Fig. 1.
In this work, we were able to verify this pathway by show-
ing (i) that the products formed by CitG from ATP and de-
phospho-CoA are indeed adenine and 2P-(5Q-triphosphoribo-
syl)-3P-dephospho-CoA and (ii) that the latter compound is
transferred by CitX to apo-ACP to yield holo-ACP.
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2. Materials and methods
2.1. Puri¢cation of proteins
Puri¢cation of E. coli apo-ACPHis, E. coli CitGHis, and E. coli
CitXStrep was performed as described previously [13]. The purity of
the proteins was checked by SDS^polyacrylamide gel electrophoresis
(PAGE) [24] and subsequent staining of the gels with Coomassie
brilliant blue. Protein concentrations were determined with the bicin-
choninic acid protein assay [25] using ovalbumin as the standard.
2.2. CitG assay and reversed phase chromatography
The function of CitG was analyzed by incubating puri¢ed CitGHis
(30 WM) with ATP (30 WM) and dephospho-CoA (30 WM) at room
temperature for 90 min. Subsequently the mixture was heated to 80‡C
for 7 min and heat-denatured CitG was removed by centrifugation.
The compounds remaining in the supernatant were separated by re-
versed phase chromatography essentially as described previously [13].
A Hypersil ODS column (250 mmU4 mm, 5 Wm particle size, Hew-
lett-Packard) was equilibrated with bu¡er A (0.2 M potassium phos-
phate pH 5.0) at a £ow rate of 1 ml/min. Elution was performed with
a linear gradient (0^60% within 18 min) of bu¡er B (0.2 M potassium
phosphate pH 5.0 containing 20% (v/v) acetonitrile) with UV detec-
tion at 254 nm. The peak fractions were collected and stored at
320‡C for further analysis.
2.3. Mass spectrometric analysis of the prosthetic group precursor
The fraction of the high performance liquid chromatography
(HPLC) peak eluting at 13.5 min was evaporated to dryness and
redissolved in half the volume water. 1 Wl of this solution was mixed
with the same volume of a saturated matrix solution (2,5-dihydroxy-
benzoic acid in an aqueous solution of 33% acetone) and allowed to
dry at room temperature. Spectra (positive ion mode) were recorded
with a Voyager Elite matrix-assisted laser desorption ionization^time-
of-£ight (MALDI-TOF) mass spectrometer (Perseptive Biosystems,
Framingham, MA, USA) in the delayed extraction and re£ector
mode using an accelerating voltage of 20 kV, a pulse delay time of
150 ns, a grid voltage of 75% and a guide wire voltage of 0.05%.
Spectra were averaged from 32 scans. Calibration was external to
the samples.
For the mass determination of apo-ACPHis and holo-ACPHis, a
saturated matrix solution of sinapinic acid (3,5-dimethoxy-4-hy-
droxy-trans-cinnamic-acid) in 60% acetonitrile/0.1% tri£uoroacetic
acid was utilized. The samples were analyzed in delayed extraction
linear mode using an accelerating voltage of 25 kV, a pulse delay time
of 350 ns, a grid voltage of 92% and a guide wire voltage of 0.15%.
Spectra were averaged from 50 scans. Calibration was external to the
samples.
3. Results
3.1. In vitro synthesis of the prosthetic group precursor
In order to test our proposal that the ¢rst step in the syn-
thesis of the citrate lyase prosthetic group is the CitG-cata-
lyzed formation of a precursor from ATP and dephospho-
CoA, puri¢ed E. coli CitGHis (30 WM) was incubated for 90
min at room temperature with ATP (30 WM) and dephospho-
CoA (30 WM). Subsequently the assay mixture was heated to
80‡C for 7 min. After removal of the heat-denatured protein
by centrifugation, the supernatant was subjected to reversed
phase HPLC. The HPLC chromatogram presented in Fig. 2A
shows the peaks observed for a reference sample that con-
tained 30 WM of each ATP and dephospho-CoA and had
also been incubated at 80‡C. The peaks eluting at 5.6 min
and 15.6 min represent ATP and dephospho-CoA, respec-
tively. The third dominant peak eluting at 7.7 min results
from a degradation product of dephospho-CoA. According
to the pathway shown in Fig. 1, two products should be
formed by CitG from ATP and dephospho-CoA, i.e. adenine
and 2P-(5Q-triphosphoribosyl)-3P-dephospho-CoA. The elution
pro¢le obtained with the protein-free supernatant shown in
Fig. 2B revealed residual amounts of ATP (5.5 min) and de-
phospho-CoA (15.7 min) and two dominant new peaks with
retention times of 9.0 min and 13.5 min. If the protein-free
supernatant was supplemented with 0.05 mM commercially
available adenine, an increase of the peak eluting at 9 min
was observed (Fig. 2C), showing that this peak represents
adenine. Consequently, the compound eluting at 13.5 min
was assumed to represent the prosthetic group precursor syn-
thesized by CitG from ATP and dephospho-CoA. As de-
scribed below, this assumption could be veri¢ed. In addition
to the dominant new peaks at 9.0 min and 13.5 min, the
protein-free supernatant of the CitG assay mixture contained
a smaller new peak with a retention time of 5.9 min. This peak
was shown to represent ADP.
3.2. Mass determination of the prosthetic group precursor
In order to determine the mass of the compound eluting at
13.5 min, the corresponding HPLC fraction was evaporated
to dryness, redissolved in half the volume H2O, and subjected
to MALDI-TOF mass spectrometry. The obtained mass spec-
trum (Fig. 3) revealed seven major peaks with the following
m/z values: 1060.6, 1098.6, 1136.5, 1174.5, 1212.5, 1250.5 and
1288.4. The calculated monoisotopic mass for the 1-fold pro-
tonated species (M+H) of 2P-(5Q-triphosphoribosyl)-3P-de-
phospho-CoA, the precursor predicted by us, is 1060.6 Da,
which corresponds exactly to the lowest m/z value measured.
The six peaks with higher m/z values can be readily explained
by the exchange of the protons of the phosphate groups by
one to maximally six potassium ions originating from the
bu¡er (see Fig. 1). This interpretation agrees with the calcu-
Fig. 1. Pathway for the synthesis of the 2P-(5Q-phosphoribosyl)-3P-de-
phospho-CoA prosthetic group of citrate lyase in E. coli and
K. pneumoniae.
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lated mass di¡erence of 38 Da between two consecutive mass
peaks.
3.3. In vitro conversion of apo-ACP and
triphosphoribosyl-dephospho-CoA into holo-ACP by CitX
Final con¢rmation of 2P-(5Q-triphosphoribosyl)-3P-dephos-
pho-CoA as a precursor of the prosthetic group of citrate
lyase ACP required that the compound is transferred by
CitX to apo-ACP yielding holo-ACP. For this purpose, puri-
¢ed apo-ACPHis (31.5 WM) and CitXStrep (1.7 WM) were mixed
either in the presence or the absence of the HPLC-puri¢ed
prosthetic group precursor. At di¡erent time points after start
of the reaction, samples were taken and analyzed by SDS^
PAGE (Fig. 4). In the samples containing triphosphoribosyl-
dephospho-CoA, a conversion of the apo-ACPHis (apparent
molecular mass 12.5 kDa) to holo-ACPHis (apparent molec-
ular mass 15.0 kDa) was observed as shown by the retarded
migration. In the samples taken 15 min and 30 min after start
of the reaction, about 50% of apo-ACPHis had been converted
to holo-ACPHis. This incomplete conversion was due to the
limiting amount of prosthetic group precursor, since a further
addition of precursor at 30 min led to further conversion of
the apo-form (Fig. 4, lane 8). In the samples where the po-
tential precursor of the prosthetic group was omitted, no con-
version of apo-ACPHis into a larger-sized from was detected.
Apo-ACPHis and the product formed in vitro by CitX from
apo-ACPHis and 2P-(5Q-triphosphoribosyl)-3P-dephospho-CoA
were analyzed by MALDI-TOF mass spectrometry. The ob-
tained chromatograms are shown in Fig. 5. The apo-ACPHis
yielded a mass of 11 755.1 Da, which deviates 0.002% from
the calculated average mass (M+H) of 11 755.3 Da. The
putative holo-ACPHis sample yielded a mass of 12 637.8 Da.
Substraction gives a mass di¡erence of 882.7 Da, which ex-
actly corresponds to the predicted mass of the prosthetic
group. This experiment con¢rmed that 2P-(5Q-triphosphoribo-
syl)-3P-dephospho-CoA indeed represents the precursor of the
Fig. 2. HPLC analysis of substrates used and products formed in vi-
tro by CitG. CitGHis (30 WM) was incubated for 90 min at room
temperature with ATP (30 WM) and dephospho-CoA (30 WM). After
removal of the heat-denatured protein by centrifugation, the super-
natant was subjected to reversed phase chromatography either with-
out added adenine (B) or together with 0.05 mM adenine (C). As a
reference, a sample containing 30 WM of both ATP and dephospho-
CoA was analyzed (A). For detection, the UV absorption at 254
nm was measured.
Fig. 3. MALDI-TOF mass spectrum obtained from the HPLC-puri-
¢ed precursor (retention time 13.5 min) of the citrate lyase pros-
thetic group.
Fig. 4. In vitro conversion of apo-ACP into holo-ACP by CitX
with the HPLC-puri¢ed prosthetic group precursor. Puri¢ed apo-
ACPHis and CitXStrep were incubated in the absence or presence of
2P-(5Q-triphosphoribosyl)-3P-dephospho-CoA. After 30 min at room
temperature, the latter assay mixture was supplemented again with
2P-(5Q-triphosphoribosyl)-3P-dephospho-CoA. Aliquots were taken at
the indicated times and subjected to SDS^PAGE. The gel was
stained with Coomassie brilliant blue. Lane 1 contains a protein
standard.
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citrate lyase prosthetic group. Furthermore, it demonstrated
that CitX alone is su⁄cient to catalyze the transfer of the
prosthetic group precursor to apo-ACP resulting in the for-
mation of holo-ACP.
4. Discussion
In this work, studies are presented that ¢nally veri¢ed our
recent proposal on the reactions involved in the biosynthesis
of the citrate lyase prosthetic group 2P-(5Q-phosphoribosyl)-3P-
dephospho-CoA (Fig. 1). In the ¢rst step, CitG catalyzes an
unusual K-1,2-glycosidic linkage between ATP and dephos-
pho-CoA, leading to the formation of the prosthetic group
precursor 2P-(5Q-triphosphoribosyl)-3P-dephospho-CoA and
adenine, both of which were identi¢ed in our in vitro system.
Thus, CitG functions as a 2P-(5Q-triphosphoribosyl)-3P-de-
phospho-CoA synthase. In the second step, the prosthetic
group precursor is transferred by CitX to apo-ACP, resulting
in the formation of holo-ACP and pyrophosphate (data not
shown). Thus, CitX functions as apo-citrate lyase phosphor-
ibosyl-dephospho-CoA transferase. The attachment of the
prosthetic group occurs via a phosphodiester linkage to ser-
ine-14 of the Q-subunit in the citrate lyase enzymes of
K. pneumoniae and E. coli.
By performing two separate in vitro experiments in order to
investigate the two reaction steps of the synthesis of the citrate
lyase prosthetic group, it was shown that CitG and CitX are
able to act independently of each other. However, the fact
that in some bacteria CitX and CitG are fused [13] indicates
that under physiological conditions the two enzymes closely
interact. We observed that the same amount of the prosthetic
group precursor was produced by CitG in vitro if the sub-
strates ATP and dephospho-CoA were present either in the
same concentration as CitG or in 5-fold excess (data not
shown). This indicates that the prosthetic group precursor is
not released from CitG but remains attached to it until the
group is captured by CitX and then transferred to apo-ACP.
The presence of a 2P-(5Q-phosphoribosyl)-3P-dephospho-
CoA prosthetic group is not restricted to citrate lyase but
also occurs in the ACPs of citramalate lyase (EC 4.1.3.22)
from Clostridium tetanomorphum [26], as well as in malonate
decarboxylase (EC 4.1.1) from Malonomonas rubra [27],
K. pneumoniae [28], and Acinetobacter calcoaceticus [29]. Re-
cent studies with K. pneumoniae malonate decarboxylase have
shown that the biosynthesis pathway of the prosthetic group
involves the same reactions as shown in Fig. 1, but uses ge-
netically distinct enzymes (Hoenke, Wild and Dimroth, sub-
mitted).
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